Composite hemangioendothelioma with neuroendocrine marker expression: an aggressive variant
Authors:
- 1 November 2017
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 30 (11) , 1589-1602
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Prox1 Transcription Factor as a Marker for Vascular Tumors—Evaluation of 314 Vascular Endothelial and 1086 Nonvascular TumorsAmerican Journal of Surgical Pathology, 2012
- Ossifying Fibromyxoid Tumor of Soft PartsAmerican Journal of Surgical Pathology, 2011
- Composite haemangioendothelioma: report of four cases with emphasis on atypical clinical presentationPathology, 2011
- Composite haemangioendothelioma with lymph-node metastasis: an unusual presentation at an uncommon siteClinical and Experimental Dermatology, 2009
- Anastomosing Hemangioma of the Genitourinary TractAmerican Journal of Surgical Pathology, 2009
- Composite hemangioendothelioma of the oral cavity: Case report and review of the literatureHead & Neck, 2008
- Cutaneous composite hemangioendothelioma with satellitosis and lymph node metastasesJournal of Cutaneous Pathology, 2007
- Composite cutaneous haemangioendothelioma treated with interferonJournal of the European Academy of Dermatology and Venereology, 2007
- Composite cutaneous haemangioendothelioma: case report and review of the literatureClinical and Experimental Dermatology, 2005
- Papillary Intralymphatic Angioendothelioma (PILA)American Journal of Surgical Pathology, 1999